<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37766226</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>26</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Multiple Factors Influence the Incubation Period of ALS Prion-like Transmission in SOD1 Transgenic Mice.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1819</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v15091819</ELocationID><Abstract><AbstractText>Mutations in superoxide dismutase 1 (SOD1) that are associated with amyotrophic lateral sclerosis (ALS) cause its misfolding and aggregation. Prior studies have demonstrated that the misfolded conformation of ALS-SOD1 can template with na&#xef;ve SOD1 "host proteins" to propagate, spread, and induce paralysis in SOD1 transgenic mice. These observations have advanced the argument that SOD1 is a host protein for an ALS conformer that is prion-like and experimentally transmissible. Here, we investigated the propagation of different isolates of G93A-SOD1 ALS conformers using a paradigm involving transmission to mice expressing human G85R-SOD1 fused to yellow fluorescent protein (G85R-SOD1:YFP). In these studies, we also utilized a newly developed line of mice in which the G85R-SOD1:YFP construct was flanked by loxp sites, allowing its temporal and spatial regulation. We used methods in which the G93A ALS conformers were injected into the sciatic nerve or hindlimb muscle of adult transgenic mice. We observed that the incubation period to paralysis varied significantly depending upon the source of inoculum containing misfolded G93A SOD1. Serial passage and selection produced stable isolates of G93A ALS conformers that exhibited a defined minimum incubation period of ~2.5 months when injected into the sciatic nerve of young adult mice. As expected, neuronal excision of the transgene in loxpG85R-SOD1:YFP mice blocked induction of paralysis by transmission of G93A ALS conformers. Our findings indicate that G93A ALS conformers capable of inducing disease require neuronal expression of a receptive host SOD1 protein for propagation, with a defined incubation period to paralysis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ayers</LastName><ForeName>Jacob I</ForeName><Initials>JI</Initials><AffiliationInfo><Affiliation>Institute for Neurodegenerative Disease, University of California, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Guilian</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-9630-1534</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dillon</LastName><ForeName>Kristy</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fromholt</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borchelt</LastName><ForeName>David R</ForeName><Initials>DR</Initials><Identifier Source="ORCID">0000-0002-0813-6979</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>SantaFe HealthCare Alzheimer's Disease Research Center, McKnight Brain Institute, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS092788</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011328">Prions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C000606291">Sod1 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010243" MajorTopicYN="N">Paralysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011328" MajorTopicYN="Y">Prions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">prion</Keyword><Keyword MajorTopicYN="N">seeding</Keyword><Keyword MajorTopicYN="N">superoxide dismutase-1</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37766226</ArticleId><ArticleId IdType="pmc">PMC10534885</ArticleId><ArticleId IdType="doi">10.3390/v15091819</ArticleId><ArticleId IdType="pii">v15091819</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ravits J.M., Spada A.R. La ALS motor phenotype heterogeneity, focality, and spread: Deconstructing motor neuron degeneration. Neurology. 2009;73:805&#x2013;811. doi: 10.1212/WNL.0b013e3181b6bbbd.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181b6bbbd</ArticleId><ArticleId IdType="pmc">PMC2739608</ArticleId><ArticleId IdType="pubmed">19738176</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.X. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Volk A.E., Weishaupt J.H., Andersen P.M., Ludolph A.C., Kubisch C. Current knowledge and recent insights into the genetic basis of amyotrophic lateral sclerosis. Med. Genet. 2018;30:252&#x2013;258. doi: 10.1007/s11825-018-0185-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11825-018-0185-3</ArticleId><ArticleId IdType="pmc">PMC6132774</ArticleId><ArticleId IdType="pubmed">30220791</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata N., Asayama K., Hirano A., Kobayashi M. Immunohistochemical study on superoxide dismutases in spinal cords from autopsied patients with amyotrophic lateral sclerosis. Dev. Neurosci. 1996;18:492&#x2013;498. doi: 10.1159/000111445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000111445</ArticleId><ArticleId IdType="pubmed">8940623</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi S., Stauffer J.E., Schulte D.J., Ravits J. Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants. Neurol. Clin. 2015;33:855&#x2013;876. doi: 10.1016/j.ncl.2015.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.012</ArticleId><ArticleId IdType="pmc">PMC4628785</ArticleId><ArticleId IdType="pubmed">26515626</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston J.A., Dalton M.J., Gurney M.E., Kopito R.R. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2000;97:12571&#x2013;12576. doi: 10.1073/pnas.220417997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.220417997</ArticleId><ArticleId IdType="pmc">PMC18805</ArticleId><ArticleId IdType="pubmed">11050163</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Xu G., Borchelt D.R. High molecular weight complexes of mutant superoxide dismutase 1: Age-dependent and tissue-specific accumulation. Neurobiol. Dis. 2002;9:139&#x2013;148. doi: 10.1006/nbdi.2001.0471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2001.0471</ArticleId><ArticleId IdType="pubmed">11895367</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Xu G., Gonzales V., Coonfield M., Fromholt D., Copeland N.G.G., Jenkins N.A.A., Borchelt D.R.R. Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site. Neurobiol. Dis. 2002;10:128&#x2013;138. doi: 10.1006/nbdi.2002.0498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2002.0498</ArticleId><ArticleId IdType="pubmed">12127151</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson P.A., Ernhill K., Andersen P.M., Bergemalm D., Brannstrom T., Gredal O., Nilsson P., Marklund S.L. Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis. Brain. 2004;127:73&#x2013;88. doi: 10.1093/brain/awh005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh005</ArticleId><ArticleId IdType="pubmed">14534160</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M., Hart P.J.J., Borchelt D.R.R., Andersen P.M.M. Variation in aggregation propensities among ALS-associated variants of SOD1: Correlation to human disease. Hum. Mol. Genet. 2009;18:3217&#x2013;3226. doi: 10.1093/hmg/ddp260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp260</ArticleId><ArticleId IdType="pmc">PMC2722984</ArticleId><ArticleId IdType="pubmed">19483195</ArticleId></ArticleIdList></Reference><Reference><Citation>Sangwan S., Eisenberg D.S. Perspective on SOD1 mediated toxicity in Amyotrophic Lateral Sclerosis. Postep. Biochem. 2016;62:362&#x2013;369. doi: 10.18388/pb.2016_37.</Citation><ArticleIdList><ArticleId IdType="doi">10.18388/pb.2016_37</ArticleId><ArticleId IdType="pubmed">28132491</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng Y., Chattopadhyay M., Whitelegge J., Valentine J.S. SOD1 aggregation and ALS: Role of metallation states and disulfide status. Curr. Top. Med. Chem. 2012;12:2560&#x2013;2572. doi: 10.2174/1568026611212220010.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026611212220010</ArticleId><ArticleId IdType="pubmed">23339308</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers J.I., Fromholt S.E., O&#x2019;Neal V.M., Diamond J.H., O&#x2019;Neal V.M., Diamond J.H., Borchelt D.R. Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways. Acta Neuropathol. 2016;131:103&#x2013;114. doi: 10.1007/s00401-015-1514-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1514-0</ArticleId><ArticleId IdType="pmc">PMC4699876</ArticleId><ArticleId IdType="pubmed">26650262</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers J.I., Diamond J., Sari A., Fromholt S., Galaleldeen A., Ostrow L.W., Glass J.D., Hart P.J., Borchelt D.R. Distinct conformers of transmissible misfolded SOD1 distinguish human SOD1-FALS from other forms of familial and sporadic ALS. Acta Neuropathol. 2016;132:827&#x2013;840. doi: 10.1007/s00401-016-1623-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1623-4</ArticleId><ArticleId IdType="pmc">PMC5107152</ArticleId><ArticleId IdType="pubmed">27704280</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad L.I., Yerbury J.J., Turner B.J., Guest W.C., Pokrishevsky E., O&#x2019;Neill M.A., Yanai A., Silverman J.M., Zeineddine R., Corcoran L., et al. Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. USA. 2014;111:3620&#x2013;3625. doi: 10.1073/pnas.1312245111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1312245111</ArticleId><ArticleId IdType="pmc">PMC3948312</ArticleId><ArticleId IdType="pubmed">24550511</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad L.I., Guest W.C., Yanai A., Pokrishevsky E., O&#x2019;Neill M.A., Gibbs E., Semenchenko V., Yousefi M., Wishart D.S., Plotkin S.S., et al. Intermolecular transmission of superoxide dismutase 1 misfolding in living cells. Proc. Natl. Acad. Sci. USA. 2011;108:16398&#x2013;16403. doi: 10.1073/pnas.1102645108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1102645108</ArticleId><ArticleId IdType="pmc">PMC3182705</ArticleId><ArticleId IdType="pubmed">21930926</ArticleId></ArticleIdList></Reference><Reference><Citation>Munch C., O&#x2019;Brien J., Bertolotti A. Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc. Natl. Acad. Sci. USA. 2011;108:3548&#x2013;3553. doi: 10.1073/pnas.1017275108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1017275108</ArticleId><ArticleId IdType="pmc">PMC3048161</ArticleId><ArticleId IdType="pubmed">21321227</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers J.I., Fromholt S., Koch M., DeBosier A., McMahon B., Xu G., Borchelt D.R. Experimental transmissibility of mutant SOD1 motor neuron disease. Acta Neuropathol. 2014;128:791&#x2013;803. doi: 10.1007/s00401-014-1342-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1342-7</ArticleId><ArticleId IdType="pubmed">25262000</ArticleId></ArticleIdList></Reference><Reference><Citation>Bidhendi E.E., Bergh J., Zetterstrom P., Andersen P.M., Marklund S.L., Brannstrom T. Two superoxide dismutase prion strains transmit amyotrophic lateral sclerosis-like disease. J. Clin. Investig. 2016;126:2249&#x2013;2253. doi: 10.1172/JCI84360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI84360</ArticleId><ArticleId IdType="pmc">PMC4887173</ArticleId><ArticleId IdType="pubmed">27140399</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekhtiari Bidhendi E., Bergh J., Zetterstr&#xf6;m P., Forsberg K., Pakkenberg B., Andersen P.M., Marklund S.L., Br&#xe4;nnstr&#xf6;m T. Mutant superoxide dismutase aggregates from human spinal cord transmit amyotrophic lateral sclerosis. Acta Neuropathol. 2018;136:939&#x2013;953. doi: 10.1007/s00401-018-1915-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1915-y</ArticleId><ArticleId IdType="pmc">PMC6280858</ArticleId><ArticleId IdType="pubmed">30284034</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Farr G.W., Zeiss C.J., Rodriguez-Gil D.J., Wilson J.H., Furtak K., Rutkowski D.T., Kaufman R.J., Ruse C.I., Yates J.R., III, et al. Progressive aggregation despite chaperone associations of a mutant SOD1-YFP in transgenic mice that develop ALS. Proc. Natl. Acad. Sci. USA. 2009;106:1392&#x2013;1397. doi: 10.1073/pnas.0813045106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0813045106</ArticleId><ArticleId IdType="pmc">PMC2631083</ArticleId><ArticleId IdType="pubmed">19171884</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers J.I., Xu G., Dillon K., Lu Q., Chen Z., Beckman J., Moreno-Romero A.K., Zamora D.L., Galaleldeen A., Borchelt D.R. Variation in the vulnerability of mice expressing human superoxide dismutase 1 to prion-like seeding: A study of the influence of primary amino acid sequence. Acta Neuropathol. Commun. 2021;9:92. doi: 10.1186/s40478-021-01191-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-021-01191-w</ArticleId><ArticleId IdType="pmc">PMC8139116</ArticleId><ArticleId IdType="pubmed">34016165</ArticleId></ArticleIdList></Reference><Reference><Citation>Crown A., McAlary L., Fagerli E., Brown H., Yerbury J.J., Galaleldeen A., Cashman N.R., Borchelt D.R., Ayers J.I. Tryptophan residue 32 in human Cu-Zn superoxide dismutase modulates prion-like propagation and strain selection. PLoS ONE. 2020;15:e0227655. doi: 10.1371/journal.pone.0227655.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0227655</ArticleId><ArticleId IdType="pmc">PMC6991973</ArticleId><ArticleId IdType="pubmed">31999698</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Xu G., Li H., Gonzales V., Fromholt D., Karch C., Copeland N.G.G., Jenkins N.A.A., Borchelt D.R.R. Somatodendritic accumulation of misfolded SOD1-L126Z in motor neurons mediates degeneration: AlphaB-crystallin modulates aggregation. Hum. Mol. Genet. 2005;14:2335&#x2013;2347. doi: 10.1093/hmg/ddi236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddi236</ArticleId><ArticleId IdType="pubmed">16000321</ArticleId></ArticleIdList></Reference><Reference><Citation>Elroy-Stein O., Bernstein Y., Groner Y. Overproduction of human Cu/Zn-superoxide dismutase in transfected cells: Extenuation of paraquat-mediated cytotoxicity and enhancement of lipid peroxidation. EMBO J. 1986;5:615&#x2013;622. doi: 10.1002/j.1460-2075.1986.tb04255.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1986.tb04255.x</ArticleId><ArticleId IdType="pmc">PMC1166807</ArticleId><ArticleId IdType="pubmed">3011416</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers J.I.I., Fromholt S., Sinyavskaya O., Siemienski Z., Rosario A.M.M., Li A., Crosby K.W.W., Cruz P.E.E., DiNunno N.M.M., Janus C., et al. Widespread and efficient transduction of spinal cord and brain following neonatal AAV injection and potential disease modifying effect in ALS mice. Mol. Ther. 2015;23:53&#x2013;62. doi: 10.1038/mt.2014.180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2014.180</ArticleId><ArticleId IdType="pmc">PMC4426802</ArticleId><ArticleId IdType="pubmed">25228069</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H., Polymenidou M., Cleveland D.W. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 2009;187:761&#x2013;772. doi: 10.1083/jcb.200908164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200908164</ArticleId><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y., Romero M.I., Ghosh P., Ye Z., Charnay P., Rushing E.J., Marth J.D., Parada L.F. Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes Dev. 2001;15:859&#x2013;876. doi: 10.1101/gad.862101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.862101</ArticleId><ArticleId IdType="pmc">PMC312666</ArticleId><ArticleId IdType="pubmed">11297510</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratovitski T., Corson L.B., Strain J., Wong P., Cleveland D.W., Culotta V.C., Borchelt D.R. Variation in the biochemical/biophysical properties of mutant superoxide dismutase 1 enzymes and the rate of disease progression in familial amyotrophic lateral sclerosis kindreds. Hum. Mol. Genet. 1999;8:1451&#x2013;1460. doi: 10.1093/hmg/8.8.1451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/8.8.1451</ArticleId><ArticleId IdType="pubmed">10400992</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchelt D.R., Lee M.K., Slunt H.S., Guarnieri M., Xu Z.-S., Wong P.C., Brown R.H., Jr., Price D.L., Sisodia S.S., Cleveland D.W., et al. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc. Natl. Acad. Sci. USA. 1994;91:8292&#x2013;8296. doi: 10.1073/pnas.91.17.8292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.17.8292</ArticleId><ArticleId IdType="pmc">PMC44592</ArticleId><ArticleId IdType="pubmed">8058797</ArticleId></ArticleIdList></Reference><Reference><Citation>Keskin I., Ekhtiari Bidhendi E., Marklund M., Andersen P.M., Br&#xe4;nnstr&#xf6;m T., Marklund S.L., Nordstr&#xf6;m U. Peripheral administration of SOD1 aggregates does not transmit pathogenic aggregation to the CNS of SOD1 transgenic mice. Acta Neuropathol. Commun. 2021;9:111. doi: 10.1186/s40478-021-01211-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-021-01211-9</ArticleId><ArticleId IdType="pmc">PMC8220797</ArticleId><ArticleId IdType="pubmed">34158126</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzpatrick A.W.P., Falcon B., He S., Murzin A.G., Murshudov G., Garringer H.J., Crowther R.A., Ghetti B., Goedert M., Scheres S.H.W. Cryo-EM structures of tau filaments from Alzheimer&#x2019;s disease. Nature. 2017;547:185&#x2013;190. doi: 10.1038/nature23002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature23002</ArticleId><ArticleId IdType="pmc">PMC5552202</ArticleId><ArticleId IdType="pubmed">28678775</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;vestam S., Koh F.A., van Knippenberg B., Kotecha A., Murzin A.G., Goedert M., Scheres S.H.W. Assembly of recombinant tau into filaments identical to those of Alzheimer&#x2019;s disease and chronic traumatic encephalopathy. Elife. 2022;11:e76494. doi: 10.7554/eLife.76494.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.76494</ArticleId><ArticleId IdType="pmc">PMC8983045</ArticleId><ArticleId IdType="pubmed">35244536</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweighauser M., Shi Y., Tarutani A., Kametani F., Murzin A.G., Ghetti B., Matsubara T., Tomita T., Ando T., Hasegawa K., et al. Structures of &#x3b1;-synuclein filaments from multiple system atrophy. Nature. 2020;585:464&#x2013;469. doi: 10.1038/s41586-020-2317-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2317-6</ArticleId><ArticleId IdType="pmc">PMC7116528</ArticleId><ArticleId IdType="pubmed">32461689</ArticleId></ArticleIdList></Reference><Reference><Citation>Boillee S., Yamanaka K., Lobsiger C.S., Copeland N.G., Jenkins N.A., Kassiotis G., Kollias G., Cleveland D.W. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312:1389&#x2013;1392. doi: 10.1126/science.1123511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K., Chun S.J., Boillee S., Fujimori-Tonou N., Yamashita H., Gutmann D.H., Takahashi R., Misawa H., Cleveland D.W. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 2008;11:251&#x2013;253. doi: 10.1038/nn2047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2047</ArticleId><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobsiger C.S., Boillee S., McAlonis-Downes M., Khan A.M., Feltri M.L., Yamanaka K., Cleveland D.W. Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice. Proc. Natl. Acad. Sci. USA. 2009;106:4465&#x2013;4470. doi: 10.1073/pnas.0813339106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0813339106</ArticleId><ArticleId IdType="pmc">PMC2657393</ArticleId><ArticleId IdType="pubmed">19251638</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn L.I., Becher M.W., Lee M.K., Anderson K.L., Jenkins N.A., Copeland N.G., Sisodia S.S., Rothstein J.D., Borchelt D.R., Price D.L., et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron. 1997;18:327&#x2013;338. doi: 10.1016/S0896-6273(00)80272-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(00)80272-X</ArticleId><ArticleId IdType="pubmed">9052802</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato S., Takikawa M., Nakashima K., Hirano A., Cleveland D.W., Kusaka H., Shibata N., Kato M., Nakano I., Ohama E. New consensus research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 (SOD1) gene mutations: Inclusions containing SOD1 in neurons and astrocytes. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2000;1:163&#x2013;184. doi: 10.1080/14660820050515160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820050515160</ArticleId><ArticleId IdType="pubmed">11464950</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Grisotti G., Roos R.P. Mutant SOD1 knockdown in all cell types ameliorates disease in G85R SOD1 mice with a limited additional effect over knockdown restricted to motor neurons. J. Neurochem. 2010;113:166&#x2013;174. doi: 10.1111/j.1471-4159.2010.06594.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.06594.x</ArticleId><ArticleId IdType="pmc">PMC2913968</ArticleId><ArticleId IdType="pubmed">20132483</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo L., Ambrozkiewicz M.C., Benseler F., Chen C., Dumontier E., Falkner S., Furlanis E., Gomez A.M., Hoshina N., Huang W.-H., et al. Optimizing Nervous System-Specific Gene Targeting with Cre Driver Lines: Prevalence of Germline Recombination and Influencing Factors. Neuron. 2020;106:37&#x2013;65.e5. doi: 10.1016/j.neuron.2020.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.01.008</ArticleId><ArticleId IdType="pmc">PMC7377387</ArticleId><ArticleId IdType="pubmed">32027825</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M., Borchelt D.R. Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states. Mol. Neurodegener. 2011;6:77. doi: 10.1186/1750-1326-6-77.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-6-77</ArticleId><ArticleId IdType="pmc">PMC3248846</ArticleId><ArticleId IdType="pubmed">22094223</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>